MERRILL LYN ACCEL RTN NTS LKD BIOTECH IDX 9/04
BTC
BTC was delisted on the 30th of September, 2004.
0 hedge funds and large institutions have $0 invested in MERRILL LYN ACCEL RTN NTS LKD BIOTECH IDX 9/04 in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $905K → $0 (-$905K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GMCM
Gruber & McBaine Capital Management
San Francisco,
California
|
-$905K |
BTC Hedge Fund Activity: Q3 2013 in Review
0 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in MERRILL LYN ACCEL RTN NTS LKD BIOTECH IDX 9/04 (BTC) for Q3 2013, worth a combined $0 — down 100% from $905K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BTC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Gruber & McBaine Capital Management, exiting entirely with an estimated $905K sold.
- 0 institutional investors held MERRILL LYN ACCEL RTN NTS LKD BIOTECH IDX 9/04 (BTC) as of Q3 2013, down from 1 in Q2 2013.
- Funds reported $0 of MERRILL LYN ACCEL RTN NTS LKD BIOTECH IDX 9/04 stock for Q3 2013, down 100% quarter-over-quarter.
- 0 funds opened new MERRILL LYN ACCEL RTN NTS LKD BIOTECH IDX 9/04 positions in Q3 2013 and 1 closed out, a net change of -1 holder.
- The largest MERRILL LYN ACCEL RTN NTS LKD BIOTECH IDX 9/04 seller in Q3 2013 was Gruber & McBaine Capital Management, an estimated $905K sold.
Based on aggregated 13F filings for Q3 2013.